Export 90 results:
Author Title Type [ Year(Desc)]
Filters: Author is Cruz, F.  [Clear All Filters]
2009
Da Silva, C. M., & Cruz, F. (2009). Has botulinum toxin therapy come of age: What do we know, what do we need to know, and should we use it?. Current Opinion in Urology, 19(4), 347 - 352.
Guimarães, M., Oliveira, R., Pinto, R., Soares, A., et al. (2009). Intermediate-term results, up to 4 years, of a bone-anchored male perineal sling for treating male stress urinary incontinence after prostate surgery. BJU International, 103(4), 500 - 504.
Silva, J., Pinto, R., Carvalho, T., Botelho, F., et al. (2009). Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: Duration of the effect of a single treatment. BMC Urology, 9(1).
Silva, J., Pinto, R., Carvallho, T., Coelho, A., et al. (2009). Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat. European Urology, 56(1), 134 - 141.
Ferreira, S. G., Lomaglio, T., Avelino, A., Cruz, F., et al. (2009). N-acyldopamines control striatal input terminals via novel ligand-gated cation channels. Neuropharmacology, 56(3), 676 - 683.
Andersson, K. - E., Chapple, C. R., Cardozo, L., Cruz, F., et al. (2009). Pharmacological treatment of overactive bladder: Report from the International Consultation on Incontinence. Current Opinion in Urology, 19(4), 380 - 394.
Cruz, F., Silva, J., Pinto, R., Carvallho, T., et al. (2009). Reply to Tomasz Drewa, Zbigniew Wolski and Janusz Tyloch's Letter to the Editor re: João Silva, Rui Pinto, Tiago Carvallho, et al. Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat. Eur. European Urology, 56(5), e28 - e29.
Oliveira, R., Silva, A., Pinto, R., Silva, J., et al. (2009). Short-term assessment of a tension-free vaginal tape for treating female stress urinary incontinence. BJU International, 104(2), 225 - 228.
2010
Tomada, N., Tomada, I., Cruz, F., Vendeira, P., & Neves, D. (2010). Characterization of VEGF and angiopoietins expression in human corpus cavernosum during aging. Journal of Sexual Medicine, 7(4 PART 1), 1410 - 1418.
Coelho, A., Dinis, P., Pinto, R., Gorgal, T., et al. (2010). Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder. European Urology, 57(5), 884 - 890.
Cruz, F., & Desgrandchamps, F. (2010). New Concepts and Pathophysiology of Lower Urinary Tract Symptoms in Men. European Urology, Supplements, 9(4), 472 - 476.
Pinto, R., Frias, B., Allen, S., Dawbarn, D., et al. (2010). Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience, 166(3), 907 - 916.
Pinto, R., Lopes, T., Frias, B., Silva, A., et al. (2010). Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Journal of Urology, 184(4), 1364 - 1365.
Pinto, R., Lopes, T., Frias, B., Silva, A., et al. (2010). Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. European Urology, 58(3), 360 - 365.
Birder, L. A., Kanai, A. J., Cruz, F., Moore, K., & Fry, C. H. (2010). Is the urothelium intelligent?. Neurourology and Urodynamics, 29(4), 598 - 602.
Botelho, F., Pina, F., Silva, P., Figueiredo, G., et al. (2010). Vascular endothelial growth factor (VEGF) and prostate pathology. International Braz J Urol, 36(4), 430 - 437.
2011
Tomada, N., Tomada, I., Botelho, F., Cruz, F., & Vendeira, P. (2011). Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment. Journal of Sexual Medicine, 8(3), 831 - 839.
Antunes-Lopes, T., Carvalho-Barros, S., Cruz, C. - D., Cruz, F., & Martins-Silva, C. (2011). Biomarkers in overactive bladder: A new objective and noninvasive tool?. Advances in Urology.
Cruz, F., Herschorn, S., Aliotta, P., Brin, M., et al. (2011). Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: A randomised, double-blind, placebo-controlled trial. European Urology, 60(4), 742 - 750.
Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Exploratory study assessing efficacy and complications of TVT-O, TVT-Secur, and Mini-Arc: Results at 12-month follow-up. European Urology, 59(6), 940 - 944.
Silva, J., Pinto, R., Carvalho, T., Botelho, F., et al. (2011). Intraprostatic botulinum toxin type A administration: Evaluation of the effects on sexual function. BJU International, 107(12), 1950 - 1954.
Athanasopoulos, A., & Cruz, F. (2011). The medical treatment of overactive bladder, including current and future treatments. Expert Opinion on Pharmacotherapy, 12(7), 1041 - 1055.
Charrua, A., Avelino, A., & Cruz, F. (2011). Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A. Handbook of Experimental Pharmacology (Vol. 202, pp. 345 - 374).
Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Reply from authors re: Elisabetta costantini and massimo lazzeri. Surgery for stress urinary incontinence: So near and yet so far. Eur Urol 2011;59:945-6. European Urology, 59(6), 947.
Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Single-incision sling system as primary treatment of female stress urinary incontinence: Prospective 12 months data from a single institution. BJU International, 108(10), 1616 - 1621.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc